... calculated at 4, 12, and 24 hours after injection,
increased as the drug diffusivity was reduced. Furthermore, the rate of
drug elimination, which is inversely related to the drug s elimination half-
life, ... Inc.
examinedthetransportkineticsofascorbateusingtherecentlydeveloped
consciousanimalmodelwithmicrodialysissamplingofaqueoushumor.
Microdialysisprobeswereplacedintheanteriorchambe...
... Animal Effect
2-Phenylethanol 0.5% Tilisolol, FD -4 , FD-
10
Rabbit Enhanced Papp 2.7 times for tilisolol, 5.6
times for FD -4 , and 4. 8 times for FD-10
Paraben 0. 04% Tilisolol, FD -4 , FD-
10
Rabbit ... applied drugs in the rabbit. Pharm. Res. 15:1882–1887, 1998.
50. Yen, W C., and Lee, V. H. L. Role of Na
+
in the asymmetric paracellular
transport of 4- phenylazobenzyloxycarbonyl-L-Pro-L...
... of drugs in perspective vis-a-vis ocular
drug delivery. First, the noncorneal penetration pathway involves the per-
meation of drug across the conjunctiva and sclera and may contribute sig-
nificantly ... Routes of delivery: case
studies. (7). Ocular delivery of peptide and protein drugs, Adv. Drug Delivery
Rev., 8:331–339.
81. Chiou, G. C. Y. (19 94) . Systemic delivery of polyp...
... Absorption of vasopressin analogue, 1-
desamino-8-D-arginine-vasopressin (dDAVP), in human intestinal epithelial
cell line, CaCO-2, Int. J. Pharm., 64: 181.
43 . Amidon, G. L., Sinko, P. J., Hu, ... Pharm.
Exp. Ther., 249 : 249 .
80. Ahmed, I., and Patton, T. F. (1985). Importance of the noncorneal absorption
route in topical ophthalmic drug delivery, Invest. Ophthalmol. Vis. Sci.,
2...
... intraocular sur-
gery. Ophthalmology 98:227–228, 1991.
24. Peyman, G. A., and Schulman, J. A. Intravitreal drug therapy. In: Intravitreal
Surgery. Norwalk: Appleton-Century-Crofts, pp. 40 7 45 5.
25. ... Inc.
Similarrelationshipsbetweenretinalpermeability,vitreousdiffusivity,mole-
cularweight,andhalf-lifehavebeenshownbyMaurice(32,36).Withinthe
rangestudied,half-lifeisinverselydependentonth...
... including polymer -drug complex sys-
tems, erodible microspheres, responsive particulates, in situ gelling systems,
ion-exchange systems, and nanoparticles (15).
B. Local Injectable Systems
When the ... PECL
nanoparticles for carteolol. It was concluded that the drug entrapped in
the oily core is more available for corneal absorption.
3
H-Labeled hydrocortisone-17-butyrate-21-propiona...
... adenovirus encoding brain-derived neurotrophic factor (Ad-
BDNF) coinjected with a free radical scavenger, N-tert-butyl-(2-sulfoph-
enyl)-nitrone (S-PBN), resulted in the survival of 63% axotomized ... myocardium.
Nature, 41 0(6829):701–705.
48 . Brown, J. M., Weissman, I. L., and Shizuru, J. A. (2001). Immunity to infec-
tions following hematopoietic cell transplantation. Curr. Opin. Immun...
... 94: 12 744 –12 746 .
99. D. Pogocki and C. Schoneich. (2000). Chemical stability of nucleic acid-
derived drugs. J. Pharm. Sci., 89 :44 3 45 6.
100. I. Jaaskelainen, J. Monkkonen, and A. Urtti. (19 94) . ... for gene delivery in vitro and in vivo. Adv. Drug Deliv. Rev., 24: 265–
271.
84. C. Plank, W. Zauner, and E. Wagner. (1998). Application of membrane-active
peptides for drug and ge...